Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.71B | 7.75B | 8.67B | 8.25B | 6.78B | Gross Profit |
3.58B | 3.30B | 3.68B | 3.63B | 2.64B | EBIT |
1.43B | 1.24B | 1.50B | 1.45B | 910.70M | EBITDA |
1.66B | 1.49B | 1.50B | 1.65B | 1.13B | Net Income Common Stockholders |
1.13B | 949.76M | 1.13B | 1.13B | 680.71M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.21B | 1.26B | 367.34M | 850.34M | 1.20B | Total Assets |
5.30B | 5.27B | 4.66B | 4.63B | 4.66B | Total Debt |
1.35B | 1.39B | 1.44B | 1.28B | 1.53B | Net Debt |
134.34M | 128.61M | 1.08B | 433.91M | 333.82M | Total Liabilities |
3.16B | 3.15B | 2.96B | 2.96B | 3.01B | Stockholders Equity |
2.14B | 2.13B | 1.70B | 1.66B | 1.65B |
Cash Flow | Free Cash Flow | |||
1.14B | 1.49B | 698.71M | 1.14B | 1.11B | Operating Cash Flow |
1.36B | 1.68B | 1.05B | 1.37B | 1.27B | Investing Cash Flow |
-221.21M | -188.26M | -353.95M | -226.25M | -168.88M | Financing Cash Flow |
-1.18B | -598.31M | -1.18B | -1.49B | -343.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $14.73B | 13.10 | 40.08% | 2.45% | 3.53% | 13.86% | |
77 Outperform | $16.95B | 28.38 | -14.74% | 1.27% | 4.28% | 13.76% | |
76 Outperform | $21.37B | 19.78 | 53.91% | 1.36% | -0.50% | 24.11% | |
69 Neutral | $15.62B | 17.24 | 31.63% | 5.11% | -4.43% | -24.58% | |
66 Neutral | $20.58B | 18.29 | 15.89% | 2.52% | 4.96% | -32.41% | |
61 Neutral | $6.98B | 11.35 | 2.88% | 3.90% | 2.65% | -21.84% | |
61 Neutral | $18.18B | ― | 18.88% | ― | -9.88% | -205.57% |